Bilateral Bronchoalveolar Lavage in Ventilator-associated Pneumonia
NCT02542553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2015-09-07
Summary
The purpose of this study is to assess microbiologic concordance rates between right- and left-lung bronchoalveolar lavage cultures from patients with suspected ventilator-associated pneumonia, identify predictors of concordance, and evaluate the impact of discordant microbiology on clinicians' ability to prescribe appropriate antibiotic treatments, the investigators conducted a prospective observational study in the general intensive care unit of a large university hospital.
Conditions
- Pneumonia, Ventilator-Associated
Interventions
- PROCEDURE
-
Bilateral BAL
Sponsors & Collaborators
-
Catholic University of the Sacred Heart
lead OTHER
Principal Investigators
-
Giuseppe Bello, MD · Università Cattolica del Sacro Cuore, Rome, Italy
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
More Related Trials
-
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528 ·Status: UNKNOWN
-
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
NCT06743529 ·Status: RECRUITING ·Phase: NA
-
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
NCT07052604 ·Status: RECRUITING
-
Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
NCT04279873 ·Status: COMPLETED
-
Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)
NCT05205525 ·Status: COMPLETED
-
Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia
NCT05464680 ·Status: COMPLETED ·Phase: NA
-
Ventilation Associated Pneumonia and Covid-19
NCT05089968 ·Status: COMPLETED
-
Inhaled Polymyxin E to Prevent VAP
NCT06819462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Microbiological Profile of VAP Patients in Respiratory ICU
NCT05738928 ·Status: UNKNOWN
-
Prognosis and Virulence Determination of Capsule and Endotoxin During Klebsiella Spp. Ventilator-associated Pneumonias
NCT05450796 ·Status: UNKNOWN
-
Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19
NCT04358211 ·Status: NO_LONGER_AVAILABLE
-
Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections
NCT04359693 ·Status: COMPLETED
-
Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage
NCT03927079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
NCT02478710 ·Status: TERMINATED ·Phase: PHASE4
-
Antimicrobial Stewardship Program and Ventilator Associated Pneumonia
NCT04097899 ·Status: COMPLETED
-
Impact of Direct Antimicrobial Susceptibility Testing on Respiratory Sample of Intensive Care Patient With Suspected VAP
NCT02897466 ·Status: UNKNOWN ·Phase: NA
-
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
NCT02413242 ·Status: COMPLETED
-
Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit
NCT03046082 ·Status: COMPLETED
-
Strategies to Prevent Pneumonia (SToP Pneumonia)
NCT00234598 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Molecular Characterization of Bacteria From ICU and From the REHAB
NCT03475472 ·Status: COMPLETED
-
Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients
NCT03303937 ·Status: COMPLETED
-
Lipid Kinetics of Patients With Pneumonia
NCT04748432 ·Status: COMPLETED
-
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
NCT03382548 ·Status: COMPLETED ·Phase: PHASE3
-
Early Antibiotics After Aspiration in ICU Patients
NCT05079620 ·Status: TERMINATED ·Phase: PHASE4
-
Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients
NCT03413293 ·Status: UNKNOWN